Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

By Sabrina Valle NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives ...

The Army Corps of Engineers will complete as soon as next week its revised list of energy projects that could be fast-tracked ...

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production.

Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

The U.S. Treasury on Friday lifted economic sanctions against Tornado Cash, a firm that makes cryptocurrency transactions ...

By Mariam Sunny (Reuters) -Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories ...

US benchmark equity indexes ended higher Tuesday as traders parsed the latest economic data and remarks by a Federal Reserve governor. * New-home sales in the US increased less than expected in ...

Chevron bought about 4.99% of Hess Corp's common shares this year, reflecting its confidence in completing the planned acquisition of Hess, the oil giant said in a regulatory filing on Monday.

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...